Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Service-Line Insights Are Informing Growth Strategies for Provider Organizations
-
Concurrent Technologies Corporation Appoints Marion Kennedy as Vice President, Digital Mission Solutions
-
California Resources Corporation Schedules Third Quarter 2026 Earnings Conference Call
-
AlphaSense and EIU Partner to Bring Independent Economic and Geopolitical Intelligence to AlphaSense's Decision-Grade AI Platform
-
Ex-China Tungsten Supply Runs 21,000 Tonnes Short as 2027 Ban Nears
-
AI order-to-cash platform Stuut raises $52.5M Series B after unlocking 40% more cash for enterprises
-
Integrity Care Group Enters Two New States and Strengthens Core Market with Acquisition of 15 NextCare Clinics; Now Offers Access to High-Quality Healthcare in 100 Clinics Across Five States
-
LPL Financial Welcomes Legacy Financial Group
-
DFW Voters Name Highland Homes Top Winner for 5th Year
-
Artelo Biosciences Selected for its First-Ever Company Presentation at BIO-Europe 2026 to Showcase Clinical Progress and Expanding Potential of its Novel FABP5 Inhibitor Platform
-
Circle8 Netherlands Secures $314 Million Four-Year Contract With DUO Groningen
-
Tessera: Zorronet Reports Growing Operational Deployments of Its Natural-Language AI Platform in Defense and Critical Infrastructure
-
Avaí Bio and Austrianova Hold First Joint Steering Committee Meeting with Ospedale San Raffaele for Diabetes Cell Therapy Program
-
Moleculin Biotech to Participate in Advances in Oncology Panel at the 2026 Maxim Growth Summit
-
Itron Advances Grid Reliability with New Outage Awareness and Fault Prevention Solution
-
WISeSat.Space to Ring the Nasdaq Opening Bell on October 9 and Highlight Secure Space Infrastructure Strategy at Convene Quantum Space Security Roundtable
-
Commure Appoints Nick Apeland as President of Go-to-Market
-
Tria Federal Launches Healthcare Trilemma Campaign to Open a New Conversation in Federal Health
-
Clearmind Advances Dialogue with U.S. Federal Government on Psychedelic Therapies, Submitting Recommendations to FDA
-
NetraMark Founder Dr. Joseph Geraci to Participate in H.C. Wainwright’s AI-Based Drug Discovery and Development Conference
-
Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity™ Urinary Management Portfolio
-
Invitation to HMS Networks’ third quarter conference call 2026
-
Uncertainty about future skills is emerging as the next workforce risk, says WTW
-
AIB Data Centers Issues CEO Letter Highlighting Recent Milestones and CLT1 Development Strategy
-
HireQuotient Announces an Integration with BambooHR to Bring AI-Native Recruiting to Frontline Industries
-
Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications
-
SIOS Technology Expands Leadership Team to Support Global Growth and Rising Demand for Application Resilience
-
TOMI Environmental Solutions Confirms Readiness to Support Biosecurity Preparedness and Front-Line Response Worldwide
-
Q.E.P. CO., INC. Declares Regular Quarterly Cash Dividend
-
Fusemachines Launches fuse.ai to Showcase the Future of AI Twins in the Workplace
-
Mint Enters into OEM Supply and License Agreement with Ireland-based Centridex to Expand into Europe
-
Hard Rock Stadium Selects Clover Sport to Power Point-of-Sale Solutions
-
Alliance Entertainment Announces October 2026 Investor Conference Schedule
-
BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence
-
Cyllene Therapeutics Presents Interim Data from Phase 1b/2a Clinical Trial Showing EG110A Reduced Urinary Episodes in Patients with Spinal Cord Injury at the International Continence Society (ICS) Con
-
Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition with PRP in Pancreatic Cancer Models, Contrasting Profile with Revolution Medicines’ Daraxonrasib
-
Dave’s Hot Chicken Gives Everyone a Free Slider on Dave’s Day; October 13 Marks the Fourth Annual Giveaway
-
Theialife Announces Positive Type C Meeting with FDA for ND10 in Progressive Myopia
-
RenovoRx Advances TAMP™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial
-
OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company’s Real World Data Footprint into Korea and the Asia Pacific Region
-
AVAX One Announces Significant Balance Sheet Progress In Third Quarter 2026
-
Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million
-
SEMA4D Blockade Reshapes the Tumor Immune Environment in Neoadjuvant Melanoma Study
-
DeFi Development Corp. to Participate in the 2026 Maxim Growth Summit
-
Beeline to Host Stakeholder Update Call on Q3 2026 Financial Results
-
Notification under Chapter 9, Section 10 of the Securities Market Act: Holdings of Töysän Säästöpankkisäätiö in Oma Savings Bank Plc has fallen below the flagging threshold
-
Notification under Chapter 9, Section 10 of the Securities Market Act: Holdings of Kuortaneen Säästöpankkisäätiö in Oma Savings Bank Plc has fallen below the flagging threshold
-
Apryse Expands Document SDKs to Reduce Custom Development Across AI, Editing and Capture Workflows
-
Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics
-
SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company’s Quantum A
